HGBL, nos
Clinical trials for HGBL, nos explained in plain language.
Never miss a new study
Get alerted when new HGBL, nos trials appear
Sign up with your email to follow new studies for HGBL, nos, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
A CAR-T therapy given by injection: can it help Hard-to-Treat lymphoma?
Cure Recruiting nowResearchers are testing a new CAR-T cell therapy called C402-CD19-CAR in adults with large B-cell lymphoma that has come back or stopped responding to treatment. The therapy is made from each participant's own T cells, which are modified to target CD19, a marker on lymphoma cells…
Matched conditions: HGBL, NOS
Phase 1 • Sponsor: Shanghai Exuma Biotechnology Ltd. • Aim: Cure
Last updated Sep 13, 2026 00:00 UTC
-
New combo therapy aims to boost CAR t-cell success in hard-to-treat blood cancers
Disease control Recruiting nowThis early-phase study tests a radioactive drug (131-I apamistamab) given before CAR T-cell therapy for people with relapsed or hard-to-treat B-cell acute lymphoblastic leukemia or diffuse large B-cell lymphoma. The goal is to find a safe dose and see if the combination is tolera…
Matched conditions: HGBL, NOS
Early phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC